| pubmed-article:15683478 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0087111 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0020205 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0004238 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0004239 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0016229 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C1274040 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0574032 | lld:lifeskim |
| pubmed-article:15683478 | lifeskim:mentions | umls-concept:C0443252 | lld:lifeskim |
| pubmed-article:15683478 | pubmed:dateCreated | 2005-2-1 | lld:pubmed |
| pubmed-article:15683478 | pubmed:abstractText | The flecainide infusion test has been proposed to screen candidates for hybrid pharmacological and ablation therapy. We report the long-term follow-up of 154 consecutive patients with paroxysmal or persistent atrial fibrillation (AF) who developed atrial flutter (AFL) during flecainide infusion (IC AFL), treated with inferior vena cava-tricuspid annulus isthmus catheter ablation and oral flecainide (hybrid therapy). Over a mean of 54.1 +/- 13.1 months 82 patients (53%) remained free of AF and AFL. Flecainide was discontinued because of adverse effects in 6 patients (4%). A history of persistent AF, and the documentation of >/=1 spontaneous AFL episode before the flecainide test were independent predictors of successful hybrid therapy. In patients with paroxysmal AF without documented spontaneous AFL, the long-term efficacy of hybrid therapy was 38.5% (P = 0.03). The flecainide infusion test reliably detects candidates for hybrid therapy. The efficacy of this therapy is maintained over the long-term with a high patient compliance. | lld:pubmed |
| pubmed-article:15683478 | pubmed:language | eng | lld:pubmed |
| pubmed-article:15683478 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15683478 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:15683478 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15683478 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:15683478 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:15683478 | pubmed:month | Jan | lld:pubmed |
| pubmed-article:15683478 | pubmed:issn | 0147-8389 | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:TurcoPietroP | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:StabileGiusep... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:El... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:VitaleDino... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:MessinaVincen... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:De... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:La... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:NocerinoPasqu... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:GrecoLucianoL | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:AstaritaCosta... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:RotunnoRaffae... | lld:pubmed |
| pubmed-article:15683478 | pubmed:author | pubmed-author:Di... | lld:pubmed |
| pubmed-article:15683478 | pubmed:issnType | Print | lld:pubmed |
| pubmed-article:15683478 | pubmed:volume | 28 Suppl 1 | lld:pubmed |
| pubmed-article:15683478 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:15683478 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:15683478 | pubmed:pagination | S124-7 | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:meshHeading | pubmed-meshheading:15683478... | lld:pubmed |
| pubmed-article:15683478 | pubmed:year | 2005 | lld:pubmed |
| pubmed-article:15683478 | pubmed:articleTitle | Long-term results of hybrid therapy in patients with atrial fibrillation who develop atrial flutter during flecainide infusion. | lld:pubmed |
| pubmed-article:15683478 | pubmed:affiliation | Laboratorio di Elettrofisiologia, Villa Maria Cecilia Hospital, Cotignola (RA), Italy. | lld:pubmed |
| pubmed-article:15683478 | pubmed:publicationType | Journal Article | lld:pubmed |
| http://linkedlifedata.com/r... | pubmed:referesTo | pubmed-article:15683478 | lld:pubmed |
